News and Trends 16 Dec 2022
Alchemab Therapeutics receives £1.7M grant to work on therapy for Huntington’s disease
Alchemab Therapeutics has been awarded a grant of £1.7 million ($2 million) from Innovate UK’s Biomedical Catalyst (BMC) 2022 funding…